Matches in SemOpenAlex for { <https://semopenalex.org/work/W1607916537> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1607916537 endingPage "1252" @default.
- W1607916537 startingPage "1244" @default.
- W1607916537 abstract "CTL recognize oligopeptides bound to MHC class I molecules. Immunization of animals with antigenic peptides has often failed to stimulate CTL responses. We confirm that immunizations with several peptides, including natural and optimally active antigenic sequences, do not prime cytotoxic immunity in mice. However, immunization with peptides together with human beta 2-microglobulin primes Ag-specific CTL. Priming is observed when animals receive injections either i.v. with ex vivo peptide/beta 2-microglobulin-pulsed cells or s.c. with an admixture of peptide and beta 2-microglobulin. beta 2-Microglobulin promotes the priming of CTL immunity if it is added with peptide, but not if it is added after cells are exposed to peptide. Synthetic peptides and mixtures of peptides from enzymatically cleaved Ag are immunogenic. When a tryptic digest of OVA or the synthetic peptide (OVA258-276) are used as immunogens, the CTL that respond recognize the endogenously processed epitope presented by an OVA-transfected target cell. The peptide + beta 2-microglobulin-primed CTL are CD4-CD8+ and are class I MHC restricted. Using the immunization protocol with beta 2-microglobulin, we have primed CTL responses with peptides from OVA, Sendai virus, and vesicular stomatitis virus. These results may explain previous failures to prime CTL with peptides in vivo and provide a novel approach for developing peptide-based vaccines for viral diseases." @default.
- W1607916537 created "2016-06-24" @default.
- W1607916537 creator A5014281383 @default.
- W1607916537 creator A5030390672 @default.
- W1607916537 creator A5082096834 @default.
- W1607916537 date "1993-02-15" @default.
- W1607916537 modified "2023-10-13" @default.
- W1607916537 title "Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant." @default.
- W1607916537 doi "https://doi.org/10.4049/jimmunol.150.4.1244" @default.
- W1607916537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8381832" @default.
- W1607916537 hasPublicationYear "1993" @default.
- W1607916537 type Work @default.
- W1607916537 sameAs 1607916537 @default.
- W1607916537 citedByCount "30" @default.
- W1607916537 countsByYear W16079165372015 @default.
- W1607916537 countsByYear W16079165372016 @default.
- W1607916537 crossrefType "journal-article" @default.
- W1607916537 hasAuthorship W1607916537A5014281383 @default.
- W1607916537 hasAuthorship W1607916537A5030390672 @default.
- W1607916537 hasAuthorship W1607916537A5082096834 @default.
- W1607916537 hasBestOaLocation W16079165371 @default.
- W1607916537 hasConcept C100701293 @default.
- W1607916537 hasConcept C147483822 @default.
- W1607916537 hasConcept C147969180 @default.
- W1607916537 hasConcept C154317977 @default.
- W1607916537 hasConcept C159047783 @default.
- W1607916537 hasConcept C167672396 @default.
- W1607916537 hasConcept C170627219 @default.
- W1607916537 hasConcept C195616568 @default.
- W1607916537 hasConcept C202751555 @default.
- W1607916537 hasConcept C203014093 @default.
- W1607916537 hasConcept C21957315 @default.
- W1607916537 hasConcept C2522874641 @default.
- W1607916537 hasConcept C2779281246 @default.
- W1607916537 hasConcept C2780127873 @default.
- W1607916537 hasConcept C55493867 @default.
- W1607916537 hasConcept C59822182 @default.
- W1607916537 hasConcept C81444415 @default.
- W1607916537 hasConcept C86803240 @default.
- W1607916537 hasConceptScore W1607916537C100701293 @default.
- W1607916537 hasConceptScore W1607916537C147483822 @default.
- W1607916537 hasConceptScore W1607916537C147969180 @default.
- W1607916537 hasConceptScore W1607916537C154317977 @default.
- W1607916537 hasConceptScore W1607916537C159047783 @default.
- W1607916537 hasConceptScore W1607916537C167672396 @default.
- W1607916537 hasConceptScore W1607916537C170627219 @default.
- W1607916537 hasConceptScore W1607916537C195616568 @default.
- W1607916537 hasConceptScore W1607916537C202751555 @default.
- W1607916537 hasConceptScore W1607916537C203014093 @default.
- W1607916537 hasConceptScore W1607916537C21957315 @default.
- W1607916537 hasConceptScore W1607916537C2522874641 @default.
- W1607916537 hasConceptScore W1607916537C2779281246 @default.
- W1607916537 hasConceptScore W1607916537C2780127873 @default.
- W1607916537 hasConceptScore W1607916537C55493867 @default.
- W1607916537 hasConceptScore W1607916537C59822182 @default.
- W1607916537 hasConceptScore W1607916537C81444415 @default.
- W1607916537 hasConceptScore W1607916537C86803240 @default.
- W1607916537 hasIssue "4" @default.
- W1607916537 hasLocation W16079165371 @default.
- W1607916537 hasLocation W16079165372 @default.
- W1607916537 hasOpenAccess W1607916537 @default.
- W1607916537 hasPrimaryLocation W16079165371 @default.
- W1607916537 hasRelatedWork W1549922507 @default.
- W1607916537 hasRelatedWork W1568417978 @default.
- W1607916537 hasRelatedWork W1605884721 @default.
- W1607916537 hasRelatedWork W1920792271 @default.
- W1607916537 hasRelatedWork W1943478869 @default.
- W1607916537 hasRelatedWork W1980621729 @default.
- W1607916537 hasRelatedWork W2053857329 @default.
- W1607916537 hasRelatedWork W2130720757 @default.
- W1607916537 hasRelatedWork W2381180037 @default.
- W1607916537 hasRelatedWork W2413210317 @default.
- W1607916537 hasVolume "150" @default.
- W1607916537 isParatext "false" @default.
- W1607916537 isRetracted "false" @default.
- W1607916537 magId "1607916537" @default.
- W1607916537 workType "article" @default.